Chinese PE Firm Huagai Capital Leads $14M Fresh Round In Bio-Therapeutics Developer

Login to View

GeneQuantum Healthcare, a Chinese high-tech company focused on the research and development of innovative bio-therapeutics, announced on Wednesday that it has raised nearly RMB100 million (US$14.76 million) in a pre-B round of financing led by private equity firm Huagai Capital.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS